medigraphic.com
Instituto Nacional de Salud Pública

2024, Number 4

<< Back Next >>

salud publica mex 2024; 66 (4)

Detection of prediabetes and diabetes

Rojas-Martínez R, Escamilla-Núñez C, Castro-Porras L, Gómez-Velasco D, Romero-Martínez M, Hernández-Serrato MI, López-Ridaura R, Díaz MÁ, Aguilar-Salinas C

Language: Spanish
References: 23
Page: 520-529
PDF size: 319.18 Kb.


ABSTRACT

Objective. Design and evaluate a risk score for prediabetes and diabetes in undiagnosed adults aged 20 years and older in Mexico from 2021 to 2023. The score is developed with information from Encuesta Nacional de Salud y Nutrición (Ensanut) Continua 2021-2023 and will be used to develop public health recommendations. Materials and methods. Using the information from adults aged 20 years and older participating in the Ensanut Continua 2021-2023. Multiple logistic regression models are presented for prediabetes and undiagnosed diabetes. Results. The proposed cut-off points of the final models obtained: sensitivity of 68.3%, specificity 70.1%, a percentage of correctly classified of 69.6%. The risk of having prediabetes or diabetes was 29%. Conclusion. The risk score worked well and may be useful for screening, besides, It allows you to identify the people most vulnerable to prediabetes or diabetes and makes recommendations to health authorities for improvement.


REFERENCES

  1. Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA,Moreno-Banda GL, Carnalla M, et al. Prevalencia de prediabetes y diabetesen México: Ensanut 2022. Salud Publica Mex. 2023;65(supl 1):163-8.https://doi.org/10.21149/14832

  2. Arredondo A, Aviles R. Costs and epidemiological changes of chronicdiseases: implications and challenges for health systems. PloS One.2015;10(3):e0118611. https://doi.org/10.1371/journal.pone.0118611

  3. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, MassaroJM, et al. General cardiovascular risk profile for use in primary care: theframingham heart study. Circulation. 2008;117(6):743-53. https://doi.org/10.1161/CIRCULATIONAHA.107.699579

  4. Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Avila MA, Gaona B, etal. Prevalence and distribution of type 2 diabetes mellitus in Mexican adultpopulation: a probabilistic survey. Salud Publica Mex. 2010;52(suppl 1):19-26. https://doi.org/10.1590/s0036-36342010000700005

  5. Hostalek U. Global epidemiology of prediabetes - present andfuture perspectives. Clin Diabetes Endocrinol. 2019;5(1):5. https://doi.org/10.1186/s40842-019-0080-0

  6. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes:a high-risk state for diabetes development. Lancet. 2012;379(9833):2279-90. https://doi.org/10.1016/S0140-6736(12)60283-9

  7. American Diabetes Association Professional Practice Committee.Diagnosis and classification of diabetes: standards of care in diabetes-2024.Diabetes Care. 2024;47(suppl 1):20-42. https://doi.org/10.2337/dc24-S002

  8. Shamah-Levy T, Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, et al. Encuesta Nacional deSalud y Nutrición 2021 sobre Covid-19. Resultados nacionales. Cuernavaca,México: Instituto Nacional de Salud Pública, 2022 [citado enero 23,2024]. Disponible en: https://ensanut.insp.mx/encuestas/ensanutcontinua2021/doctos/informes/220804_Ensa21_digital_4ago.pdf

  9. World Health Organization. Package of essential noncommunicable(PEN) disease interventions for primary health care in low-resource set-tings. Ginebra: WHO, 2020 [citado enero 25, 2024]. Disponible en: https://iris.who.int/bitstream/handle/10665/44260/97892415?sequence=1

  10. Carey RM, Wright JT, Taler SJ, Whelton PK. Guideline-driven managementof hypertension: an evidence-based update. Circulation Res.2021;128(7):827-46. https://doi.org/10.1161/CIRCRESAHA.121.318083

  11. Romero-Martínez M, Shamah-Levy T, Barrientos-Gutiérrez T, Cuevas-NasuL, Bautista-Arredondo S, Colchero MA, et al. Encuesta Nacional de Saludy Nutrición 2023: metodología y avances de la Ensanut Continua 2020-2024.Salud Publica Mex. 2023;65(4):394-401. https://doi.org/10.21149/15081

  12. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C,Handler J, et al. 2014 Evidence-based guideline for the management of highblood pressure in adults. Report from the panel members appointed tothe eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20.https://doi.org/10.1001/jama.2013.284427

  13. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome-a new worldwidedefinition. A consensus statement from the international diabetesfederation. Diabetic Medicine. 2006;23(5):469-80. https://doi.org/10.1111/j.1464-5491.2006.01858.x

  14. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA,et al. Diagnosis and management of the metabolic syndrome: an AmericanHeart Association/National Heart, Lung, and Blood Institute scientificstatement. Circulation. 2005;112(17):2735-52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404

  15. IPAQ-Group. Guidelines for data processing and analysis of theInternational Physical Activity Questionnaire (IPAQ) – Short and longforms November 2005. IPAQ, 2005 [citado enero 20, 2024]. Disponibleen: https://www.academia.edu/5346814/Guidelines_for_Data_Processing_and_Analysis_of_the_International_Physical_Activity_Questionnaire_IPAQ_Short_and_Long_Forms_Contents

  16. Rojas-Martínez R, Escamilla-Núñez C, Castro-Porras L, Gómez-VelascoD, Romero-Martínez M, Hernández-Serrato M, et al. Anexo 1. Comparaciónde los pesos asociados a los factores de riesgo considerados enel puntaje de riesgo de las propuestas de la ADA, LA-FINDRISC, SSA ynuestra propuesta. México y otros países. México: Figshare, 2024. https://doi.org/10.6084/m9.figshare.26106859

  17. Bernabe-Ortiz A, Smeeth L, Gilman RH, Sánchez-Abanto JR,Checkley W, Miranda JJ, et al. Development and validation of asimple risk score for undiagnosed type 2 diabetes in a resourceconstrainedsetting. J Diabetes Res. 2016;2016:8790235. https://doi.org/10.1155/2016/8790235

  18. Pires de Sousa AG, Costa-Pereira A, Marquezine GF, Marques doNascimento-Neto R, Freitas SN, de C Nicolato RL, et al. Derivation andexternal validation of a simple prediction model for the diagnosis of type2 diabetes mellitus in the Brazilian urban population. Eur J Epidemiol.2009;24:101-9. https://doi.org/10.1007/s10654-009-9314-2

  19. Nieto-Martínez R, González-Rivas JP, Ugel E, Marulanda MI, Durán M,Mechanick JI, et al. External validation of the finnish diabetes risk score inVenezuela using a national sample: The EVESCAM. Primary Care Diabetes.

  20. 2009;13(6):574-82. https://doi.org/10.1016/j.pcd.2019.04.00620. Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples.Inhalation Toxicol. 2014;26(13):811-28. https://doi.org/10.3109/08958378.2014.955932

  21. Rojas-Martínez R, Escamilla-Nuñez C, Castro-Porras L, Gómez-VelascoD, Romero-Martínez M, Aguilar-Salinas CA. Cardiovascular risk factorsand vascular complications in adults with early- and late-onset diabetes inMexico. Ensanut 2018. Salud Publica Mex. 2024;66(3):277-87. https://doi.org/10.21149/15786

  22. Centro Nacional de Programas Preventivos y Control de Enfermedades.Cuestionario de factores de riesgo. Ciudad de México: SS [citadoenero 20, 2024]. Disponible en: http://www.cenaprece.salud.gob.mx/programas/interior/adulto/descargas/pdf/DIABETES.pdf

  23. Rojas-Martínez R, Escamilla-Núñez C, Gómez-Velasco DV, Zárate-RojasE, Aguilar-Salinas CA, Grupo colaborador de la cohorte para estimarla incidencia del síndrome metabólico. Diseño y validación de un scorepara detectar adultos con prediabetes y diabetes no diagnosticada. SaludPublica Mex. 2018;60(5):500-09. https://doi.org/10.21149/9057




2020     |     www.medigraphic.com